// App-Quantinova.ai

TPS4154 : GLOBAL BALLAD: An International Rare Cancers Initiative trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma (IRCI 002).

Researchers

Presenter

  • T.R. Jeffry Evans

Principal Investigators

  • Karine Le Malicot

  • Kenichi Nakamura

  • Yoshitaka Honma

  • Robert R. McWilliams

  • Albert J. Ten Tije

  • David Alan Anthoney

  • Ruth Boyd

  • Judith Dixon-Hughes

  • Janet Shirley Graham

  • Timothy Iveson

  • Jonathan Nicoll

  • James Paul

  • Manuel Salto-Tellez

  • Naureen Starling

  • Makoto Ueno

  • Kein Yim

  • John A. Bridgewater

  • Richard H. Wilson

Medical Centers

  • Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, United Kingdom

  • Centre Hospitalier Universitaire Avicenne, APHP, Bobigny, France

  • FFCD, Dijon, France

  • Japan Clinical Oncology Group Data Center, National Cancer Center, Tokyo, Japan

  • Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

  • Mayo Clinic, Rochester, MN

  • Amphia Ziekenhuis, Breda, Netherlands

  • St James's Institute of Oncology, St. James's University Hospital, West Yorkshire, United Kingdom

  • Belfast City Hospital, Belfast, United Kingdom

  • Cancer Research UK Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Southampton General Hospital, Salisbury, United Kingdom

  • North Cumbria University Hospitals, Carlisle, United Kingdom

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • Queen's Univeristy Belfast, Centre for Cancer and Cell Biology, Belfast, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Division of Hepatobiliary and Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan

  • Velindre NHS Trust, Cardiff, United Kingdom

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom

Locations

  • Japan

  • Netherlands

  • United Kingdom

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small bowel adenocarcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Randomized

  • Open Label

  • Multinational

  • Multicenteric

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A